XLO
Xilio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.71
+0.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.79x
- Price / sales
- 0.89x
- Price / cash flow
- -0.95x
Enterprise value
- Enterprise value
- -$72.4M
- EV / sales
- -1.13x
- EV / EBITDA
- 3.53x
- EV / EBIT
- 2.31x
- Market cap
- $57.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026